greeksoup/ stock research
Stock research / United States / NVS / Year to 31 December 2017

Novartis AG (NVS) annual results, year to 31 December 2017: revenue USD 42,381 million, from the 20-F

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2017 it reported revenue from the sale of goods of USD 42,381 million, down 12.6% on the year before. Its profit attributable to shareholders was USD 7,703 million, up 14.8%, and diluted earnings per share USD 3.25.

Revenue
USD 42,381 million
-12.6% on the year
FY2016FY2017
Operating margin
20.5%
17.0% a year earlier
FY2016FY2017
Net income
USD 7,703 million
+14.8% on the year
FY2016FY2017
Diluted EPS
USD 3.25
+16.1% on the year
FY2016FY2017

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2016Dec 2017 †
Revenue from the sale of goods48,51842,381
Cost of sales17,52013,633
Gross profit31,91629,771
Research and development9,0398,389
Selling, general and administrative14,19212,465
Operating profit8,2688,702
Profit before tax7,8179,102
Income tax1,1191,603
Profit for the year6,6987,703
Profit attributable to shareholders6,7127,703
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2016Dec 2017 †
Diluted EPS2.803.25
Basic EPS2.823.28
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2016Dec 2017 †
Cash from operations11,47512,621
Purchase of property, plant and equipment1,8621,325
Free cash flow9,61311,296
Cash from investing-3,441-3,119
Cash from financing-5,314-7,733
Buybacks1,1095,490
Dividends paid6,4756,495
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2016Dec 2017 †
Funded by
Equity attributable to shareholders74,89174,168
Non-controlling interestsn/a59.0
Borrowings, as filedn/a23,583
Other liabilitiesn/a35,269
Total equity and liabilitiesn/a133,079
Owned
Property, plant and equipmentn/a16,464
Goodwilln/a31,750
Other intangible assetsn/a29,997
Cash and cash equivalents7,0078,860
Inventoriesn/a6,867
Other assetsn/a39,141
Total assetsn/a133,079
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2016Dec 2017 †
Return on year-end equity9.0%10.4%
Effective tax rate14.3%17.6%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2017, filed 29 January 2020: the filing. The figures are in US dollars as filed.